When does MUSTANG BIO INC (MBIO) report earnings?
MUSTANG BIO INC (MBIO) will report earnings on 2026-05-12.
MUSTANG BIO INC (MBIO) Forecast, Price Target & Analyst Ratings
NASDAQ:MBIO • US62818Q3020
Current stock price
0.775 USD
+0.01 (+1.96%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MUSTANG BIO INC (MBIO).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.78 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
MBIO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MBIO.
In the previous month the buy percentage consensus was at a similar level.
MBIO was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | BTIG | Maintains | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-16 | BTIG | Maintains | Buy |
| 2023-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-16 | BTIG | Maintains | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2021-05-18 | BTIG | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 12, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 405.45% | N/A 128.59% | N/A 41.94% | N/A 40.41% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | -31.79M | -30.59M 3.77% | -44.63M -45.90% | -55.13M -23.53% | -64.55M -17.09% | -73.44M -13.77% | -48.866M 33.46% | -11.882M 75.68% | -4.898M 58.78% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.3M | -11.36M -164.19% | -31.79M -179.84% | -31.22M 1.79% | -45.89M -46.99% | -56.81M -23.80% | -66.72M -17.44% | -76.16M -14.15% | -50.726M 33.40% | -12.553M 75.25% | -4.932M 60.71% | N/A -1,345.62% | N/A 46.92% | N/A 157.41% | N/A 201.41% | N/A 92.52% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -862.50 -29.59% | -975.00 -13.04% | -862.50 11.54% | -570.00 33.91% | -562.50 1.32% | -316.00 43.82% | N/A 90.16% | N/A 42.62% | N/A 88.69% | N/A 47.98% | N/A 157.28% | N/A 201.69% | N/A 92.13% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
26.70%
EPS Next 5 Year
17.03%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MUSTANG BIO INC / MBIO Forecast FAQ
Can you provide the analyst count for MUSTANG BIO INC stock?
The number of analysts covering MUSTANG BIO INC (MBIO) is 7.